Marie Kosco-Vilbois
Keine laufenden Positionen mehr
Karriereverlauf von Marie Kosco-Vilbois
Ehemalige bekannte Positionen von Marie Kosco-Vilbois
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AC IMMUNE SA | Technik-/Wissenschafts-/F&E-Leiter | 03.01.2019 | 01.01.2024 |
| NOVIMMUNE SA | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | 09.01.2019 |
| Serono Pharmaceutical Research Institute | Corporate Officer/Principal | 01.01.2001 | 01.01.2001 |
| Basel Institute for Immunology | Corporate Officer/Principal | - | - |
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | - | - |
Ausbildung von Marie Kosco-Vilbois
| Rutgers State University of New Jersey | Undergraduate Degree |
| Medical College of Virginia | Doctorate Degree |
Statistik
International
| Schweiz | 6 |
| Frankreich | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
| Serono Pharmaceutical Research Institute | |
| Glaxo-Welcomes' Research Institute |
- Börse
- Insiders
- Marie Kosco-Vilbois
- Erfahrung
